These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. ['Catatonic dilemma'. Comments on the article by H. Lausberg and R.Hellweg. Nervenarzt (1998) 69:818-822]. Northoff G Nervenarzt; 1999 May; 70(5):484-5. PubMed ID: 10407847 [No Abstract] [Full Text] [Related]
30. Neuroleptic malignant syndrome without neuroleptics. Ong KC; Chew EL; Ong YY Singapore Med J; 2001 Feb; 42(2):85-8. PubMed ID: 11358199 [TBL] [Abstract][Full Text] [Related]
35. A case of nonneuroleptic malignant syndrome. Cohen S; Fligner CL; Raisys VA; Luthi R; Dunner DL J Clin Psychiatry; 1987 Jul; 48(7):287-8. PubMed ID: 2885311 [TBL] [Abstract][Full Text] [Related]
36. All elevated creatine kinase is not neuroleptic malignant syndrome. Maniam T; Rahman MA Med J Malaysia; 1994 Sep; 49(3):252-4. PubMed ID: 7845275 [TBL] [Abstract][Full Text] [Related]
37. Successful treatment of neuroleptic malignant syndrome with bromocriptine. Janati A; Webb RT South Med J; 1986 Dec; 79(12):1567-71. PubMed ID: 3787295 [TBL] [Abstract][Full Text] [Related]
38. An atypical presentation of neuroleptic malignant syndrome: diagnostic dilemma in a critical care setting. Paul M; Michael SG; John S; Lenox RJ Respir Care; 2012 Feb; 57(2):315-7. PubMed ID: 21762565 [No Abstract] [Full Text] [Related]
39. Benign type of malignant syndrome. Lancet; 1989 Jan; 1(8628):49-50. PubMed ID: 2563034 [No Abstract] [Full Text] [Related]